We are live on
!
Find out more
GCM
Garland Capital Management Portfolio holdings
AUM
$7.27M
1-Year Est. Return
14.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.92%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$125M
AUM Growth
-$5.3M
(-4.1%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-7.66%
Top 10 Holdings %
Top 10 Hldgs %
42.14%
Holding
31
New
–
Increased
14
Reduced
15
Closed
2
Avg Time Held
9.7
quarters
Top 10 Avg Time Held
5.4
quarters
Top 20 Avg Time Held
6.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$74.2K |
| 2 |
Union Pacific
UNP
|
+$67.6K |
| 3 |
Novartis
NVS
|
+$50.1K |
| 4 |
AbbVie
ABBV
|
+$48.7K |
| 5 |
SVC
Service Properties Trust
SVC
|
+$35.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$5.11M |
| 2 |
Walmart Inc
WMT
|
+$4.06M |
| 3 |
Illinois Tool Works
ITW
|
+$110K |
| 4 |
Johnson & Johnson
JNJ
|
+$101K |
| 5 |
Microsoft
MSFT
|
+$74.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.08% |
| 2 | Healthcare | 15.61% |
| 3 | Real Estate | 13.36% |
| 4 | Financials | 13.11% |
| 5 | Consumer Staples | 13.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$608B
| $5.99M | 4.78% |
49,350
-890
| -2% | -$101K |
2013 Q2
12 quarters
|
|
|
2
Illinois Tool Works
ITW
$76.2B
| $5.66M | 4.51% |
54,300
-1,050
| -2% | -$110K |
2013 Q2
12 quarters
|
|
3
3M
MMM
$84.3B
| $5.62M | 4.48% |
38,350
-371
| -1% | -$52.3K |
2013 Q2
12 quarters
|
|
4
Pfizer
PFE
$166B
| $5.5M | 4.39% |
164,774
-1,897
| -1% | -$60.5K |
2013 Q2
12 quarters
|
|
|
5
Microsoft
MSFT
$3.99T
| $5.36M | 4.28% |
104,810
-1,430
| -1% | -$74.3K |
2013 Q2
12 quarters
|
|
6
GE Aerospace
GE
$321B
| $5.11M | 4.08% |
33,859
-470
| -1% | -$68.6K |
2013 Q2
12 quarters
|
|
7
Waste Management
WM
$85.7B
| $5M | 3.99% |
75,450
-950
| -1% | -$57.4K |
2013 Q2
12 quarters
|
|
|
DRE
8
DELISTED
Duke Realty Corp.
DRE
| $4.95M | 3.95% |
185,750
-1,700
| -0.9% | -$40K |
2013 Q2
12 quarters
|
|
9
Travelers Companies
TRV
$78.1B
| $4.86M | 3.88% |
40,800
-450
| -1% | -$50.9K |
2014 Q2
8 quarters
|
|
10
Unilever
UL
$137B
| $4.76M | 3.8% |
88,387
-800
| -0.9% | -$41.1K |
2013 Q2
12 quarters
|
|
11
JPMorgan Chase
JPM
$888B
| $4.43M | 3.54% |
71,330
-450
| -0.6% | -$28.1K |
2013 Q2
12 quarters
|
|
12
Highwoods Properties
HIW
$3.16B
| $4.35M | 3.47% |
82,325
+350
| +0.4% | +$16.9K |
2015 Q3
3 quarters
|
|
13
RTX Corp
RTX
$250B
| $4.34M | 3.46% |
67,191
-699
| -1% | -$44.7K |
2013 Q2
12 quarters
|
|
14
Chevron
CVX
$432B
| $4.29M | 3.43% |
40,946
-450
| -1% | -$45.3K |
2013 Q2
12 quarters
|
|
15
Procter & Gamble
PG
$361B
| $4.29M | 3.42% |
50,610
-290
| -0.6% | -$23.8K |
2013 Q2
12 quarters
|
|
16
PepsiCo
PEP
$175B
| $4.22M | 3.37% |
39,815
+25
| +0.1% | +$2.58K |
2013 Q2
12 quarters
|
|
|
LPT
17
DELISTED
Liberty Property Trust
LPT
| $4.18M | 3.34% |
105,330
+800
| +0.8% | +$29.1K |
2013 Q2
12 quarters
|
|
|
18
Novartis
NVS
$278B
| $4.16M | 3.32% |
56,302
+725
| +1% | +$50.1K |
2013 Q2
12 quarters
|
|
19
Cisco
CSCO
$455B
| $4.03M | 3.21% |
140,426
+450
| +0.3% | +$12.6K |
2013 Q4
10 quarters
|
|
|
20
AbbVie
ABBV
$500B
| $3.91M | 3.12% |
63,135
+800
| +1% | +$48.7K |
2016 Q1
1 quarter
|
|
21
IBM
IBM
$218B
| $3.86M | 3.08% |
26,589
+157
| +0.6% | +$22.5K |
2013 Q2
12 quarters
|
|
22
Prudential Financial
PRU
$39B
| $3.76M | 3% |
52,700
+50
| +0.1% | +$3.77K |
2013 Q2
12 quarters
|
|
23
ExxonMobil
XOM
$723B
| $3.73M | 2.97% |
39,765
-250
| -0.6% | -$22.1K |
2013 Q2
12 quarters
|
|
|
MON
24
DELISTED
Monsanto Co
MON
| $3.5M | 2.79% |
33,800
+50
| +0.1% | +$4.95K |
2016 Q1
1 quarter
|
|
25
Blackrock
BLK
$165B
| $3.38M | 2.7% |
9,885
+20
| +0.2% | +$7.03K |
2015 Q3
3 quarters
|
|
Similar funds
HL
IIGPLP
LSC
CG
LFA
SGIHM
TAC
YU
Garland Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Garland Capital Management held 31 positions worth $125M, down 4.1% from $131M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Garland Capital Management withdrew a net $9.6M in Q2 2016, closing 2 positions and reducing 15 holdings. Its most notable exit was St Jude Medical, an estimated $5.11M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Garland Capital Management added an estimated $74.2K to TotalEnergies.
- Garland Capital Management added most to TotalEnergies in Q2 2016, an estimated $74.2K increase.
- Garland Capital Management's biggest Q2 2016 reduction was Illinois Tool Works, cutting an estimated $110K.
- Garland Capital Management fully exited St Jude Medical in Q2 2016, selling an estimated $5.11M.
- Garland Capital Management's ten largest holdings make up 42% of its $125M portfolio in Q2 2016.
- Garland Capital Management opened 0 new positions and closed 2 in Q2 2016.
- Garland Capital Management's portfolio value fell 4.1% quarter-over-quarter to $125M.
Based on Garland Capital Management's 13F filing for Q2 2016, filed 18 Jul 2016.